Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Medical ethics wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Dental emergency wikipedia , lookup
Patient safety wikipedia , lookup
Antibiotic use in livestock wikipedia , lookup
Marburg virus disease wikipedia , lookup
Antimicrobial resistance wikipedia , lookup
Disinfectant wikipedia , lookup
Focal infection theory wikipedia , lookup
Electronic prescribing wikipedia , lookup
Antimicrobial copper-alloy touch surfaces wikipedia , lookup
Antimicrobial Prescribing Policy Portsmouth Hospitals NHS Trust Version 7 Name of responsible (ratifying) committee Infection Prevention and Control Management Committee and Antimicrobial Management Group Date ratified 14 May 2015 Document Manager (job title) Infection Control Doctor and Trust Antimicrobial Pharmacist Date issued 17 July 2015 Review date 16 July 2017 Electronic location Policies, Infection Prevention and Control Related Procedural Documents Antimicrobial Strategy Key Words (to aid with searching) Antimicrobial prescribing Version Tracking Version Date Ratified Brief Summary of Changes Author 7 14th May 2015 Modified to include microguide Dr S Wyllie Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 1 of 11 CONTENTS QUICK REFERENCE GUIDE....................................................................................................... 3 1. INTRODUCTION.......................................................................................................................... 4 2. PURPOSE ................................................................................................................................... 4 3. SCOPE ........................................................................................................................................ 4 4. DEFINITIONS .............................................................................................................................. 5 5. DUTIES AND RESPONSIBILITIES .............................................................................................. 6 6. PROCESS ................................................................................................................................... 6 7. TRAINING REQUIREMENTS ...................................................................................................... 8 8. REFERENCES AND ASSOCIATED DOCUMENTATION ............................................................ 8 9. EQUALITY IMPACT STATEMENT .............................................................................................. 8 10. MONITORING COMPLIANCE WITH, AND THE EFFECTIVENESS OF, PROCEDURAL DOCUMENTS ............................................................................................................................ 10 Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 2 of 11 QUICK REFERENCE GUIDE For quick reference the guide below is a summary of actions required. This does not negate the need for the document author and others involved in the process to be aware of and follow the detail of this policy. 1. All antimicrobial prescribing should be rational, appropriate and safe 2. Antimicrobial therapy should only be started with clear clinical justification which should be documented in the patient’s clinical notes. The prescription should be compliant with Trust empirical guidance i.e. “start smart” 3. Always culture (blood, sputum, urine etc) as appropriate prior to commencing or changing antibiotics 4. Antimicrobials should be started promptly on suspicion of infection, and within one hour of diagnosis of severe sepsis and potentially life-threatening infection 5. Review antimicrobial therapy daily with culture results and clinical progress 6. Switch intravenous therapy to oral as soon as possible based on clinical response 7. Stop antibiotics as soon as possible based on clinical response and culture results 8. After 48 hours a clear plan of action should be made. The five “Antimicrobial prescribing decisions” are to stop, switch, change, continue or OPAT 9. Always check antimicrobial dosage in presence of renal or hepatic dysfunction and compatibility with other medication in the current edition of the British National Formulary 10. For all patients labeled as penicillin allergic, establish history and assess risk. Cephalosporins and Carbapenems may be given if minor allergy e.g. rash but not for patients with documented anaphylactic response 11. Support for antimicrobial prescribing is available from the antimicrobial pharmacist on bleep 1973 or from microbiology ext 1718. A consultant-led microbiology service is available 24 hours a day, 7 days a week. 12. Empirical antimicrobial prescribing guidance is available on Microguide, a downloadable app which is also on the Trust intranet site. Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 3 of 11 1. INTRODUCTION Appropriate use of antimicrobials may be life-saving, but unnecessary overuse may be fatal and is contributing to the ever-increasing burden of antimicrobial resistance. Many healthcare-associated infections are precipitated by inappropriate antibiotic use e.g. Clostridium difficile, the leading cause of nosocomial diarrhoea. Inappropriate antibiotic prescribing has been shown to contribute to MRSA acquisition. Prudent use of antimicrobials is essential in the control of development of antimicrobial resistance and in the control of healthcare associated infections. Antibiotic resistant organisms are more difficult to treat (and may be untreatable), they prolong hospital admission and often cause increased morbidity and mortality. The World Health Organisation and many countries worldwide including the UK have produced strategies for the containment of antimicrobial resistance. Prudent antimicrobial use, along with infection control and improved cleanliness, surveillance of antimicrobial resistance with feedback to providers, education of professionals and the public, and making healthcare associated infection a key feature of quality and patient safety programs are all key areas for the prevention and containment of antimicrobial resistance. This document sets out the aims for antimicrobial prescribing within PHT. This policy has the full support of microbiology, pharmacy and infection prevention and control. 2. PURPOSE This policy defines the processes to ensure that antimicrobial prescribing within PHT is prudent, appropriate and safe. Proposed outcomes By adhering to this policy, antimicrobial prescribing within the Trust will be prudent, safe and appropriate, and based on the antibiotic susceptibility of diagnosed or likely pathogens. Prescribing and education on the diagnosis, management and treatment of infection will be supported by microbiology / infection experts in liaison with pharmacy and infection prevention and control. Use of intravenous antimicrobials will be minimised thereby minimising cannula-related infections including nosocomial bacteraemias. Use of antimicrobials especially broad spectrum antibacterials will be minimised thereby reducing the selection pressure for the development of resistant pathogens and for the development of antibiotic-associated diarrhoea, particularly C difficile. Antimicrobial prescribing practice will be supported by active surveillance and education provided by microbiology and infection control in liaison with pharmacy. 3. SCOPE This policy applies to all prescribers of antimicrobial agents within PHT. ‘In the event of an infection outbreak, flu pandemic or major incident, the Trust recognises that it may not be possible to adhere to all aspects of this document. In such circumstances, staff should take advice from their manager and all possible action must be taken to maintain ongoing patient and staff safety’ Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 4 of 11 4. DEFINITIONS Antibacterial agent A substance which selectively inhibits the growth of bacteria (bacteriostatic) or selectively kills bacteria (bacteriocidal) Antibiotic A substance produced by a micro-organism which is antagonistic to the growth or life of others in high dilution. Many antimicrobial agents are now synthetically or semi-synthetically synthesized and are thus not true antibiotics. Nevertheless the term antibiotic is widely used to refer to an antimicrobial. Antimicrobial agent A drug which is antagonistic to the growth or life of infectious pathogens, whether these are bacteria, viruses, fungi or parasites Audit The process of assessing current practices in comparison to a recognised standard Health Protection Agency Formerly the Public Health Laboratory Service, a national agency whose role is to protect the public from infection and other hazards. Hospital-acquired, healthcare associated or nosocomial infection Infection acquired in healthcare institutions. Infection Prevention and Control Team (IPCT) A group of experienced staff responsible for advising on hospital infection prevention and control. The IPCT has direct access to the Director of Infection Prevention and Control and is responsible to the Infection Prevention and Control Management Committee (IPCMC) Microbiology The study of micro-organisms Microbiologist A medical doctor qualified in the diagnosis, management and prevention of infection Microbiology ward round Also known as an antimicrobial ward round. This is a regular multi-disciplinary ward round undertaken by a microbiologist or infection specialist and a pharmacist and with a clinician who has responsibility for the patient. A member of the infection control team or a trainee microbiologist or pharmacist may also be present. The purpose of the ward round is to clinically assess the appropriateness of the antimicrobials prescribed for individual patients. All assessments take into account the current clinical situation and investigation results including any microbiology findings. Any recommendation to change the antimicrobials prescribed is discussed with the clinical staff on the wards and documented in the medical notes. The prescription chart may be actively changed by the microbiologist. Out-patient Antimicrobial Therapy (OPAT) A service provided by infection specialists to provide out-patient intravenous antimicrobial therapy Pharmacist Person qualified in the delivery, action and side-effects of medicinal drugs Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 5 of 11 5. DUTIES AND RESPONSIBILITIES All prescribers have a duty to comply with current antimicrobial prescribing guidance available on the intranet and in the British National Formulary. All prescribers should carry the empirical antimicrobial prescribing guide behind their Trust ID badge All prescribers must assess the patient’s current clinical condition and current medications, their renal and liver function and any history of allergy before prescribing an antimicrobial agent All prescribers must review their prescriptions on a regular (preferably daily) basis and rationalise any antimicrobial prescription according to the clinical state of the patient and the microbiology results Pharmacists will review all prescription charts on a regular, mostly daily, basis The antimicrobial pharmacist will coordinate the antimicrobial / microbiology ward rounds, liaise with microbiology and the infection prevention and control team with regards most appropriate treatment of infection and coordinate audits to assess compliance with the policy and Trust prescribing guidelines The microbiologists will carry out regular multi-disciplinary ward rounds with pharmacy with the aim of improving antimicrobial prescribing and providing interactive education on the wards The microbiology laboratory will deliver a timely, accurate, appropriate and efficient service The IPCT will work with Matrons, Clinical Directors, clinical leads, heads of specialties and infection control link persons to improve adherence to infection prevention and control guidelines and policies Results and actions from any audit of antimicrobial prescribing will be reported to the Director of Infection Prevention and Control via the Infection Prevention and Control Management Committee and Antimicrobial Management Group All staff have a duty of care to the patients and themselves to ensure they deliver high standards of infection control practice including antimicrobial prescribing practice at all times. Wherever there is deficiency in their knowledge or experience this must be highlighted to the department/ward manager who is responsible for ensuring the member of staff receives the appropriate training, education or advice Matron, Clinical Directors, clinical leads and heads of specialties have a duty of care to ensure that staff receive education on all aspects of infection prevention and control which relate to their workforce’s job 6. PROCESS 1. PATIENT SAFETY Antimicrobial prescribing within PHT is prudent, appropriate and safe for both the patient and the environment. Antimicrobials will be used wisely. Patients will not be exposed to unnecessary antimicrobial therapy. Antibiotics must not be started in the absence of clinical evidence of bacterial infection. 2. DOCUMENTATION OF CLINICAL NEED TO PRESCRIBE ANTIMICROBIALS The clinical indication, duration or review date, route of administration and dose all need to be clearly documented on the prescription chart and in the medical notes. Empirical antimicrobial prescribing should follow advice in the “Microguide” which is available on the front page of the intranet or is free to download to Apple and Android smartphones. 3. CORRECT DOSING AND ADMINISTRATION Antimicrobials will be administered at the most appropriate dose for treatment of infection taking into account modifications required for renal and/or liver dysfunction. Antibacterials must be started within one hour if a patient is suspected as having severe sepsis or septic shock or neutropaenic sepsis. All aminoglycoside and glycopeptide antimicrobials will be administered and monitored Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 6 of 11 according to local Trust guidelines. Antimicrobials will be administered via the most appropriate route for the clinical presentation. 4. MICROBIOLOGY SUPPORT FOR ANTIMICROBIAL PRESCRIBING Appropriate microbiological samples will be taken prior to the commencement of antimicrobial therapy. The results of these cultures will be used to rationalise the empirical prescription in the individual, to guide future empirical therapy advice and for surveillance purposes. Appropriate antimicrobial sensitivity testing will be carried out by the laboratory on clinical specimens received. A range of sensitivities will be released allowing the clinician a reasonable choice of targeted antibiotic treatments. 5. REVIEW OF ANTIMICROBIAL PRESCRIPTIONS WITH CLEAR PRESCRIBING PLAN BY 48 HOURS By 48 hours a clear antimicrobial prescribing plan should document whether antimicrobial therapy is to continue, change, stop, switch or be delivered by OPAT, i.e. an antimicrobial prescribing decision must be made and documented in the clinical notes by 48 hours. This plan will be guided by clinical progress and results of investigations including blood and culture results. Intravenous to oral switch must be considered wherever possible so avoiding the risks associated with intravenous cannulation including iatrogenic bloodstream infection and thrombosis. 6. PREFERENTIAL USE OF NARROW SPECTRUM ANTIMICROBIALS Antimicrobial therapy should be targeted to treat the specific infection using as narrow-spectrum an antimicrobial agent as is possible. Certain broad spectrum or tertiary antibacterials will only be prescribed with microbiology approval (see appendix 1; Restricted antimicrobial agents). 7. APPROPRIATE DURATION OF THERAPY Antimicrobials will be prescribed for as short a time period as possible. The duration of antimicrobial therapy depends on the infecting organism(s), the site of the infection, the patient’s own immune response and other additional features such as surgical and medical interventions. Each antimicrobial prescription needs to be assessed on a daily basis and the review documented in the clinical notes. 8. AVAILABLE GUIDANCE FOR ANTIMICROBIAL PRESCRIBING Antimicrobials will be prescribed following referenced guidelines which are available to the prescriber at the point of care as the Microguide app. These guidelines will be evidence based and written by a clinician with expertise in the area with local epidemiological knowledge. Further advice on antimicrobial prescribing can be obtained from the British National Formulary. 9. SUPPORT AND EDUCATION FOR MANAGEMENT OF INFECTION Antimicrobial prescribing is supported by regular (usually weekly) antimicrobial ward rounds carried out by microbiology in liaison with pharmacy across all acute clinical areas. Education to the junior doctors will be provided on these ward rounds. A regular program of infection updates is included in the F1/F2 junior doctor’s training. Education to senior clinicians will take place via core training programs and annual infection control updates. In addition, infection advice is available from a consultant microbiologist 24 hours a day, 7 days a week. Requirements for fulfilment of policy Sufficient numbers of qualified pharmacists to allow all prescription charts to be reviewed on a regular basis 1.0 WTE band 8a pharmacist(s) acting as the lead antimicrobial pharmacist(s) for the Trust Adequately resourced microbiology laboratory with quality assurance procedures in place. Sufficient numbers of microbiologists or infection specialists to allow regular antimicrobial ward rounds. Royal College of Pathologists guidance from 2001 states that for our current population (520,000) and renal specialist services there should be 4.0 WTE consultant Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 7 of 11 microbiologists. This guidance predates the expansion of Infection Prevention targets. There are currently 3.45 WTE consultant microbiologists Adequately resourced infection prevention and control team to support education and surveillance on antimicrobial resistance and nosocomial infection. Access for all staff in all clinical areas to computer-based and paper-based up-to-date guidelines and current copies of the British National Formulary. Senior clinical support in all clinical areas to allow regular (mostly daily) review of all antimicrobial therapy 7. TRAINING REQUIREMENTS All antimicrobial prescribers need to familiarize themselves with the Antimicrobial prescribing guidelines available on the intranet and downloadable as a Microguide App. All new medical staff will receive antimicrobial prescribing guidance from the Trust’s antimicrobial pharmacist at induction and will be advised to use the Microguide App. for antimicrobial prescribing guidance and advised on 24 hour service 7 days a week from the medical microbiologists All medical staff need to complete an annual update on infection prevention and control which includes emphasis on appropriate antimicrobial prescribing 8. REFERENCES AND ASSOCIATED DOCUMENTATION 1. Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother. 2009;64(Suppl 1):29-36 2. Hawkey, P., Jones, A. The Changing Epidemiology of Resistance. J Antimicrob Chemother. 2009; 64:Suppl 1:i3–10 3. Department of Health’s advisory committee on Antimicrobial Resistance and Healthcare associated Infection (ARHAI), Antimicrobial stewardship “Start smart, then focus”, November 2011 4. Davey, P., E. Brown, L. Fenelon, R. Finch, I. Gould, G. Hartman, A. Holmes, C. Ramsay, E. Taylor, M. Wilcox, and P. Wiffen. 2005. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst. Rev.19:CD003543 5. Dellit TH, Owens RC, McGowan JE et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clin Infect Dis. 2007;44:159-77. 6. Department of Health Chief Medical Officer. Winning ways: Working together to reduce healthcare associated infection in England. London: Department of health, 2003. 7. World Health Organisation (2001). WHO Global Strategy for containment of antimicrobial resistance. WHO, Geneva, Switzerland. 8. Surviving Sepsis Campaign: International Guidelines for the Management of Severe Sepsis and Septic Shock 2012. Dellinger RP et al. and the surviving sepsis campaign guideline committee including the paediatric subgroup. Critical Care Medicine 2013; 41(2): 580-637 9. EQUALITY IMPACT STATEMENT Portsmouth Hospitals NHS Trust is committed to ensuring that, as far as is reasonably practicable, the way we provide services to the public and the way we treat our staff reflects their individual needs and does not discriminate against individuals or groups on any grounds. This policy has been assessed accordingly Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 8 of 11 Our values are the core of what Portsmouth Hospitals NHS Trust is and what we cherish. They are beliefs that manifest in the behaviours our employees display in the workplace. Our Values were developed after listening to our staff. They bring the Trust closer to its vision to be the best hospital, providing the best care by the best people and ensure that our patients are at the centre of all we do. We are committed to promoting a culture founded on these values which form the ‘heart’ of our Trust: Respect and dignity Quality of care Working together No waste This policy should be read and implemented with the Trust Values in mind at all times. Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 9 of 11 10. MONITORING COMPLIANCE WITH PROCEDURAL DOCUMENTS Minimum requirement to be monitored Lead A minimum of 2 antimicrobial prescribing audits will be carried out each year under the supervision of the antibiotic pharmacist and the Consultant Microbiologists. Consultant Microbiologist & Pharmacist Twice yearly An annual Trust wide point prevalence audit will be carried out by microbiology and pharmacy. Consultant Microbiologist & Pharmacist Yearly Consultant Microbiologist & Pharmacist Twice yearly A minimum of 2 antimicrobial prescribing audits will be carried out each year under the supervision of the antibiotic pharmacist and the Consultant Microbiologists. Tool Frequency of Report of Compliance Reporting arrangements Policy audit report to: IPMC AMG Policy audit report to: IPMC AMG Policy audit report to: IPMC AMG Lead(s) for acting on Recommendations Dr S Wyllie Dr S Wyllie Dr S Wyllie This document will be monitored to ensure it is effective and to assurance compliance Suggested audit targets are outlined below. 90-100% of antimicrobials prescribed are clinically warranted 90-100% of antimicrobial use is documented in the patient’s notes 90-100% of antimicrobial prescribing is in accordance with local guidelines 90-100% of antimicrobials prescribed are prescribed at the correct dose 90-100% of antimicrobials prescribed are prescribed via the most appropriate route with intravenous to oral switch following local guidance 90-100% of antimicrobials prescribed which require blood levels are monitored appropriately 0-10% of antimicrobials are prescribed for longer than is necessary 90-100% of patients and their prescription charts are reviewed daily by the clinical team 90-100% of health care workers have an annual infection control update including antimicrobial prescribing Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 10 of 11 Appendix 1: Antimicrobial agents restricted for consultant physician approval (within 24 hours) Ciprofloxacin (intravenous or oral) Ertapenem Meropenem Antimicrobial agents restricted for consultant microbiologist approval only Daptomycin Linezolid Temocillin Tigecycline Voriconazole Antimicrobial Prescribing Policy Issue Number: 7 Issue Date: 17 July 2015 Review Date: 16 July 2017 (unless requirements change) Page 11 of 11